AccessBio, Inc has launched a lateral flow assay based test called CareStart COVID-19 IgM/IgG that can detect IgG and IgM antibodies in response to COVID-19, and provide results in 10 min.30 The gene discussed is CD40LG; the disease is COVID-19.